Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ribba

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Theoretical Biology|December 25, 2012
Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted miceF Lignet, S Benzekry, S Wilson, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settingsS Wilson, M Tod, A Ouerdani, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic CharacteristicsP Mazzocco, C Barthélémy, G Kaloshi, et al.
Journal of Neuro-Oncology|August 20, 2013
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapyF Ducray, G Kaloshi, C Houillier, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 10, 2015
Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something BlueM Stroh, D J Carlile, C-C Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2010
Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasiasB You, M Pollet-Villard, L Fronton, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug DevelopmentM J Swat, S Moodie, S M Wimalaratne, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Theoretical Biology|December 25, 2012
Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted miceF Lignet, S Benzekry, S Wilson, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settingsS Wilson, M Tod, A Ouerdani, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic CharacteristicsP Mazzocco, C Barthélémy, G Kaloshi, et al.
Journal of Neuro-Oncology|August 20, 2013
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapyF Ducray, G Kaloshi, C Houillier, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 10, 2015
Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something BlueM Stroh, D J Carlile, C-C Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2010
Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasiasB You, M Pollet-Villard, L Fronton, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug DevelopmentM J Swat, S Moodie, S M Wimalaratne, et al.
Pageof 2